Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Allergy & Immunology
•
Pulmonology
•
Critical Care
•
Obstructive Lung Disease
•
Asthma
Do you use continuous or intermittent bronchodilator therapy in severe airway obstruction?
Answer from: at Academic Institution
I use only intermittent.
Comments
at Medstar Health
Is that gestalt or any evidence? I really have not...
9331
Sign in or Register to read more
18063
Related Questions
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
Is methacholine challenge on its way out?
Is there a role for biologics to improve lung function in patients who have severe asthma with daily symptoms and reduced lung function but do not experience frequent exacerbations?
When would you recommend prescribing an asthmatic patient budesonide/salbutamol rather than budesonide/formoterol?
Have you observed adverse mental health side effects in patients who start montelukast?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
What factors do you consider prior to offering a trial of ICS/LABA therapy versus a methacholine challenge test in patients with suspected asthma but normal pulmonary function testing?
How do you factor smoking history into biologic selection for asthma since the clinical trials generally excluded these patients?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
Is that gestalt or any evidence? I really have not...